Viral Hepatitis Congress 2014
9–11 October 2014 Frankfurt, Germany
Digestive Disease Week
May 3-6, 2014 Chicago, Illinois
Recognized as one of the top 50 medical meetings by the Healthcare Convention & Exhibitors Association, Digestive Disease Week (DDW) is the world's leading educational forum for academicians, clinicians, researchers, students and trainees working in gastroenterology, hepatology, GI endoscopy, gastrointestinal surgery and related fields.
Whether you work in patient care, research, education or administration, the DDW program offers something for you.
DDW 2014 will be held May 3-6, 2014 at McCormick Place, Chicago, Il.
47th Annual Meeting of the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN)
June 9-12, 2014 Jerusalem, Israel
The scientific programme will include recent advances and state of the art lectures covering genetic, immunological, microbiological and clinical developments in the field of gastrointestinal disorders, liver diseases, and nutrition. There will be many opportunities to discuss and share our clinical and research field interests, to present original works, to see old friends, and to meet new colleagues.
General Information: ESPGHAN2014@mci-group.com
5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association
March 18-21, 2015 Singapore
The 5th Biennial Congress of the Asian-Pacific Hepato-Pancreato-Biliary Association (A-PHPBA) is one of region’s largest medical conferences dedicated to the study of liver, pancreas and biliary discipline. The event provides medical professionals an excellent platform for the exchange of clinical and scientific knowledge on the latest developments and emerging challenges of hepato-pancreato-biliary (HPB) disorders.
The four-day congress will feature an exciting line-up of expert speakers including top practitioners, opinion leaders and researchers. Delegates can look forward to an intensive knowledge-sharing event comprising plenary sessions, oral presentations and video screenings. There will be a host of networking opportunities for delegates to rub shoulders with top experts and opinion leaders.
Congress Secretariat for the 5th Biennial Congress of the Asian-Pacific Hepato-Pancreatro-Biliary Association
Tel: +65 6393 0202
Fax: +65 6292 7577
EASL Special Conference: Optimal Management of Hepatitis B Virus Infection
September 25-27, 2014 Athens, Greece
We anticipate that this combination of high quality presentations together with the strong reputation of the invited speakers and the relevance of the topics will bring together leading clinicians and scientists involved in Hepatitis B for what will be a memorable meeting.
EASL Monothematic Conference: Primary Biliary Cirrhosis (PBC)
May 23-24, 2014 Milan, Italy
The learning objectives:
The objectives of this conference will be to review current finding and address key open questions regarding PBC, such as:
The real role of genetics and epigenetics in the development of the disease
Why there are large geographical variations in disease frequency across Europe
Why PBC occurs predominantly in women
What causes disabling symptoms such as fatigue
Why the autoimmune attack is focused on the biliary epithelium
New theories on potential environmental triggers, such as chemical xenobiotics, will be explored together with the processes within the unique immunological milieu of the liver which lead to the breaking of self-tolerance
Currently described animal models of PBC
International Liver Congress 2014, 49th Annual Meeting of the European Association for the Study of the Liver
April 9-13, 2014 London, United Kingdom
The European Association for the Study of the Liver has selected the city of London for its 49th annual congress "The International Liver Congress, which will take place April 9-13, 2014 at the International Convention Centre ExCeL.
ILC 2014 will build on its record breaking success by providing:
Multiple opportunities to:
State-of-the-art Scientific Programme, including:
Basic Science Seminar
Young Investigator Dedicated Sessions
Nurse & Associates Forum
Abdominal Sonography Course
Webcasting & e-poster services enabling full presentations viewing
EASL Monothematic Conference: Molecular Pathogenesis & Translational Research in Liver Cancer
February 13-15, 2014 Geneva, Switzerland
Hepatocellular carcinoma is the third leading cause of cancer related to death and shows worldwide increase in incidence with being the most rapidly increasing cancer in several western world countries. In order to improve understanding of its molecular pathogenesis and provide the basis for further and more successful therapeutic approaches it is mandatory to foster basic biomedical research in hepatocellular carcinoma. While there are many conferences addressing clinical aspects of liver cancer there is an obvious lack of adequate research conferences, the EASL Monothematic Conference will address all relevant areas of current basic research in hepatocarcinogenesis; it will bring together the leading researchers with junior scientists interested in and devoted to liver cancer research and provide sufficient time for discussion around oral presentations and poster sessions.
Provide an adequate forum for leading and junior liver cancer researchers for data presentation and discussion
Update participants on status and recent achievements in liver cancer research
Outline implications of liver cancer research findings for translational research and new concepts for clinical application
Further develop the existing concepts of molecular classification of HCC and explore the potential for predictive diagnostics.
By active participation in the EASL Basic Monothematic Conference 'Molecular Pathogenesis and Translational Research in Liver Cancer' profound knowledge in the following objectives will be gained:
profound knowledge about the molecular etiology of human liver cancer, specifically how the major chronic liver diseases induce HCC and potential to perform secondary prevention in patients at risk
detailed information about the relevant molecular changes occuring in human HCC and its precursor lesions
protumorigenic molecular mechanisms leading to human HCC, their functional interaction, and means of therapeutic interference
novel therapeutic strategies currently under preclinical development or in early clinical trials
potential for predictive molecular testing in liver cancer